Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hiroshi Inagaki (Yuma Sakamoto)

Years Active: 2019-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroshi Inagaki, Takashi Ishida, Ayako Masaki, Takayuki Murase, Eiichi Ohtsuka, Morishige Takeshita, Reiji Muto, Hiromi Iwasaki, Asahi Ito, Shigeru Kusumoto, Nobuaki Nakano, Masahito Tokunaga, Kentaro Yonekura, Yukie Tashiro, Shinsuke Iida, Atae Utsunomiya, Ryuzo Ueda, Hiroshi Inagaki
CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment. Hematological oncology (2022)
Hiroshi Inagaki, Takashi Ishida, Ayako Masaki, Morishige Takeshita, Hiromi Iwasaki, Kentaro Yonekura, Yukie Tashiro, Asahi Ito, Shigeru Kusumoto, Shinsuke Iida, Atae Utsunomiya, Ryuzo Ueda, Hiroshi Inagaki
Clinicopathological significance of CD28 overexpression in adult T-cell leukemia/lymphoma. Cancer science (2021)
Hiroshi Inagaki, Takashi Ishida, Ayako Masaki, Takayuki Murase, Morishige Takeshita, Reiji Muto, Hiromi Iwasaki, Asahi Ito, Shigeru Kusumoto, Nobuaki Nakano, Masahito Tokunaga, Kentaro Yonekura, Yukie Tashiro, Shinsuke Iida, Atae Utsunomiya, Ryuzo Ueda, Hiroshi Inagaki
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma. British journal of haematology 195 (4) (2021)
Yuma Sakamoto, Keiichiro Fujii, Shunji Murase, Satsuki Nakano, Ayako Masaki, Takayuki Murase, Shigeru Kusumoto, Shinsuke Iida, Atae Utsunomiya, Ryuzo Ueda, Takashi Ishida, Hiroshi Inagaki
CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphoma. International journal of hematology 110 (4) (2019)

Hiroshi Inagaki.css-eqlu8i{font-size:small;padding-left:4px;} (Yuma Sakamoto)